Stay updated with breaking news from Neil Butt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Partnership expands spectrum of Secarna's capabilities for the development of targeted ASOs beyond antibodies and sugar molecules New platform capabilities extend the reach of Secarna's antisense
MARTINSRIED, GERMANY and OXFORD, UK - EQS Newswire - 28 May 2024 - Secarna Pharmaceuticals GmbH & Co. KG (Secarna), a leading independent European
EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): AgreementSecarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics 28.05.2024 / 13:00 CET/CESTThe issuer is solely responsible for the content of this announ...
Orano Med and Orbit Discovery have entered into a partnership for the discovery of specific peptide receptor radionuclide therapies against cancer cells.
Evergreen Discovery (Evergreen), a leading radiopharmaceutical drug development company with a focus on the treatment and diagnosis of cancer.